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Abstract  
Basal cell carcinoma (BCC) is the most common human malignancy, accounting for the majority of all non-
melanoma skin cancers (NMSC). In the past several decades the worldwide incidence of BCC has constantly 
been increasing. Even though it is a slow growing tumour that, left untreated, rarely metastasizes, it has a 
distinctive invasive growth pattern, posing a considerable risk for local invasion and destruction of underlying 
tissues, such as muscle, cartilage, bone or vital structures. Advanced BCCs include such locally invasive or 
metastatic tumours. Complete surgical excision is the standard therapy for most uncomplicated BCC cases with 
good prognosis and cure rates. Treatment of advanced forms of BCCs poses significant therapeutic challenges, 
most often requiring complicated surgery, radiotherapy, and/or targeted therapies directed towards the sonic 
hedgehog signalling pathway (SHH). We present two cases of large BCCs located on the scalp and posterior 
thorax, which underwent surgical excision with clear margins, followed by reconstruction of the defect after 
extensive undermining of the skin. 
. 
Introduction 
 
Basal cell carcinoma (BCC) is the most 
common human malignancy, accounting for the 
majority of non-melanoma skin cancers, with 
worldwide incidence rates increasing at least 2-3 fold 
in the past few decades [1,2]. It is a slow growing 
tumour with metastatic incidence rates ranging 
between 0.0028–0.55% [3]. However, in some cases, 
these tumours display a locally invasive growth 
pattern that poses a considerable risk of destruction of 
underlying cartilage, bone, or vital structures. Most 
BCCs develop in sun exposed areas of fair skinned 
individuals, mainly on the head and neck, and less 
frequently on the trunk and limbs [4, 5]. Besides 
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cutaneous phototype and exposure to UV radiation, 
other risk factors known to favor the development of 
BCC include genetic traits (including xeroderma 
pigmentosum, epidermodysplasia verruciformis, 
albinism, Gardner’s syndrome, a familial history of 
skin cancer, or DNA repair deficiencies leading to 
chromosomal instability), immunosuppression, 
repeated cutaneous trauma, or exposure to ionizing 
radiation or other environmental carcinogens (e.g. 
arsenic, alkylating agents, polycyclic aromatic 
hydrocarbons) [6-8]. 
We present two cases of BCCs located on the 
scalp and posterior thorax, managed by complete 
surgical excision, followed by reconstruction of the 
resulting defect after extensive undermining of the 
skin. This technique allowed for subsequent direct 
closure with simple sutures and an acceptable 
cosmetic outcome. 
 
 
Case report #1 - Scalp BCC 
 
An 86 year-old male was presented to the 
dermatology department for the diagnosis and 
treatment of a cutaneous tumour located on his scalp, 
which had been present for more than two years. The 
patient reported accelerated enlargement of the skin 
lesion within the last three months, associated with 
local pruritus and pain, and denied any treatment or 
medical attention before presentation. His medical 
history was positive for glaucoma, while the family 
history was unremarkable for skin cancer or other 
significant dermatological conditions.  
 
Figure 1: 1a) Cutaneous lesion on the frontoparietal region of the 
scalp; 1b) Preoperative excision markings with wide margins, 
bleeding and edema from infiltration of local anesthetic; 1c) Tumour 
is partially excised showing depth of the excision to the pericranium; 
1d-e) Primary surgical defect is extensively undermined in all 
directions to allow for coaptation of the wound edges; 1f-g) 
Placement of simple interrupted non-absorbable sutures for scalp 
defect closure; 1h) Scalp defect is completely reconstructed, ready 
for antiseptic dressings 
 
Clinical examination revealed a relatively well 
demarcated, oval shaped cutaneous tumour located 
on the scalp, featuring a “rolled border” and central 
ulceration covered by a serosanguinous crust - 
features consistent with those of basal cell carcinoma 
(Fig. 1a). Palpation of the submandibular, axillary, 
preauricular and occipital lymph nodes did not 
demonstrate enlargement or painful masses. No 
abnormalities were detected on chest x-ray. 
Concerning disease progression and invasion, an x-
ray of the calvaria did not show any bone involvement. 
On abdominal ultrasound, prostate hyperplasia, 
multiple bladder diverticula and a single 1.4 cm cyst of 
the left kidney were discovered. 
After obtaining informed consent from the 
patient, an elliptical surgical excision of the scalp 
lesion was performed under local anaesthesia with 
2% lidocaine and epinephrine (Fig. 1b–h). The 
extensive undermining of the post-excisional wound 
edges was conducted (Fig. 1d-e), followed by primary 
defect closure by placement of interrupted non-
absorbable sutures (Fig. 1f-h) and application of 
antiseptic dressings. Perioperative antibiotic 
prophylaxis was performed with administration of 2 
grammes of Ceftriaxone q.d. for five days. The patient 
was discharged with instructions for wound-care and 
follow-up for suture removal; his postoperative course 
was devoid of complications. The subsequent 
histopathological evaluation confirmed the diagnosis 
of basal cell carcinoma of the scalp. No evidence of 
metastatic spread was found with imaging procedures 
or by laboratory blood tests.  
 
Figure 2: 2a) large dermal tumor; 2b) focal connections between 
tumor cells and the epidermis; 2c) nodular masses of basaloid 
neoplastic cells with hyperchromatic nuclei, nuclear pleomorphism, 
scanty cytoplasm and peripheral palisading of nuclei; 2d) areas of 
infiltration composed of strands and chords of tumor cells that 
invade the dermal structures; 2e) foci of abrupt keratinization within 
some tumor islands; 2f) central necrosis with pseudo-cystic 
changes 
 
Histopathology: Histopathological examination 
showed a large dermal tumour (Fig. 2a), focally 
connected to the epidermis (Fig. 2b), consisting of 
nodular masses of neoplastic basaloid cells with 
hyperchromatic nuclei, nuclear pleomorphism, scanty 
cytoplasm and the peripheral palisading of nuclei 
typical of basal cell carcinoma (Fig. 2c). There were 
areas of infiltration composed of strands and chords of 
tumour cells that invaded the dermal structures (Fig. 
2d), as well as numerous foci of abrupt keratinization 
in the middle of some tumor islands (Fig. 2e). In some 
areas, there was a cleavage between the tumour cells 
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and the adjacent fibrous stroma, with mucinous 
degeneration, and the larger tumour islands showed 
central necrosis with pseudo-cystic changes (Fig. 2f). 
These findings were considered typical for a large 
nodular basal cell carcinoma with infiltrative areas, 
mucinous stromal degeneration and foci of 
keratinization. 
 
 
Case report #2 - Posterior trunk BCC 
 
A 73-year-old male presented to the 
dermatology department with a large cutaneous 
tumour located on his posterior trunk that had been 
slowly growing for more than ten years. The patient 
denied any treatment or medical attention before the 
presentation. The patient’s medical history revealed 
previous coronary bypass surgery. At the time of 
admission, he had been taking a daily dose of 
acetylsalicylic acid (ASA) as a preventative therapy, 
which before surgery was replaced with 0.6 ml 
subcutaneous nadroparin calcium twice daily. On 
examination, the tumour was located on the left 
posterior upper trunk. The skin lesion was well 
marginated, pinkish-grey in colour, with an eroded 
surface and focal bleeding (Fig. 3a).  
 
Figure 3: a) Skin lesion on the left posterior upper-trunk region; b) 
Preoperative excision markings, bleeding and oedema from local 
anaesthetic infiltration; c) Tumour is partially excised, showing 
substantial bleeding and performance of electrocautery hemostasis; 
d) Primary surgical defect is completely reconstructed, ready for 
antiseptic dressings 
 
 
No regional lymphadenopathy could be 
identified by clinical examination. Considering the long 
duration and morphology, a provisional diagnosis of 
basal cell carcinoma was made. 
Chest x-ray and lymph node ultrasonography 
of the axillary and inguinal lymph nodes did not show 
any evidence of disease progression or tumour 
spread. Abdominal ultrasonography revealed 
morphologic findings consistent with pyelonephritis 
and light hydronephrosis and urology and nephrology 
consults were requested. Informed consent was 
obtained from the patient before surgery. The upper-
trunk skin lesion was then surgically excised in an 
elliptical manner with wide margins under local 
anaesthesia with 2% lidocaine and epinephrine (Fig. 
3c). Substantial intraoperative bleeding was 
encountered, and electrocoagulation was employed. 
Following rigorous hemostasis, the extensive 
undermining of the wound edges in all directions was 
performed to allow for direct wound closure. The 
surgical defect was first approximated using 
absorbable subdermal sutures followed by placement 
of simple interrupted non-absorbable sutures (Fig. 
3d), and application of antiseptic ointment wound 
dressings. Postoperative antibiotic prophylaxis 
consisted of Clarithromycin 500 mg q.d. for ten days. 
There were no postoperative complications, and the 
patient was discharged with instructions for daily 
wound care. Follow-up visits were scheduled, and all 
sutures were removed at day twenty post-operatively.  
Histopathology: The tumour consisted of 
tightly packed large dermal nodules and 
interconnecting strands of basaloid cells with 
monomorphic nuclei, scanty cytoplasm and peripheral 
nuclear palisading. The majority of tumour nodules 
showed central cystic degenerative changes and 
pseudo-glandular spaces with mucinous contents 
(Fig. 4a-c).  
 
Figure 4: a-c) central cystic degenerative changes and pseudo-
glandular spaces with mucinous content; d) cribriform pattern with 
some resemblances to adenoid cystic carcinoma 
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Some of these areas resembled the cribriform 
pattern usually associated with adenoid cystic 
carcinoma (Fig. 4d). These features were typical for a 
large nodular basal cell carcinoma with cystic change, 
sometimes referred to as adenoid basal cell 
carcinoma. 
 
 
Discussion 
 
The main molecular alterations responsible 
for the development of BCCs include the activation of 
the sonic hedgehog signalling pathway caused by 
acquired mutations in the PTCH and SMO genes [9] 
and also mutations in P53 and melanocortin-1 
receptor genes [10, 11]. Standard therapy for the 
majority of BCCs is complete surgical excision, with 
good prognosis and cure rates. However, advanced 
BCCs, comprising locally advanced lesions and 
tumours with metastatic spread, pose significant 
therapeutic challenges and are, most often, difficult to 
treat. Advanced BCCs management is complex, 
requiring complicated surgery, radiotherapy or 
targeted therapies directed towards sonic hedgehog 
signalling pathway (SHH), either alone or in 
combination [12, 13]. 
Tumour size and location, the patient’s 
general condition, and the physician’s experience with 
particular therapeutic modalities are key 
considerations. Undermining plastic surgery has 
proven to be a good alternative to complex grafts or 
flaps for the treatment of selected cases of locally 
advanced BCCs, with the advantage of being less 
traumatic, allowing for good intraoperative control of 
clinical margins and good esthetic results [14]. Basal 
cell carcinoma is the most frequent cutaneous 
neoplasm worldwide. “Advanced” BCC, though a 
loosely defined term, comprises locally advanced and 
metastatic tumours. In a systematic review of the 
literature, Archontaki et al. (2009) analysed clinical 
and paraclinical data of 51 patients diagnosed with 
giant BCCs [15]. These investigators found a higher 
incidence of giant BCCs among elderly males aged 
between 60-70 years old. Tumours developed over a 
mean period of 14.5 years; they were located mostly 
on sun-exposed areas, primarily on the back, followed 
by the face and upper extremities, and with an 
average diameter of 14.77 cm [15]. Histopathologic 
examination revealed a predominance of the nodular 
BCC subtype [15]. There was a very high rate of post-
interventional complications, including local 
recurrences or metastases in 38.3% of cases [15]. 
Mohs micrographic surgery is currently considered the 
gold standard therapy for advanced BCCs, followed 
by wide surgical excision with complete control of 
tumour margins. Metastatic BCC now has an 
improved prognosis due to the discovery of targeted 
therapies directed towards signalling pathways like a 
sonic hedgehog, including the international availability 
of new drugs such as vismodegib and sonidegib [16, 
17]. Recent research has shown that, even though 
therapy with hedgehog inhibitors is not always 
curative for extensive BCCs, when used in 
conjunction with surgical treatment, it can significantly 
decrease the morbidity associated with surgical 
therapy while increasing the chances of obtaining 
complete resections [20]. Basal cell carcinoma of the 
trunk accounts for approximately 10 % of all BCCs 
[18], while those of the scalp region tend to be less 
common, with incidence rates of 2.6% [19]. Large 
tumour size and perineural invasion are associated 
with aggressive subtypes, and incomplete excision 
rates seem to be higher in such cases [19]. Therefore, 
Mohs micrographic surgery or standard surgical 
excision with wide margins is the best treatment 
options in advanced forms of BCC. 
In conclusion, undermining or extendable 
plastic surgery is a simple surgical approach with 
proven benefits concerning closing-tension of skin 
defects, especially in the scalp region. Published data 
confirm the fact that undermining can decrease 
tension at the wound margins, allowing good 
intraoperative control of these margins with 
diminished trauma when compared to more elaborate 
plastic surgical procedures and with potentially better 
results [14, 21]. 
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